Home » Pfizer Megadeal Still in Sight After Astra: Real M&A
Pfizer Megadeal Still in Sight After Astra: Real M&A
After being rejected by AstraZeneca, Pfizer still has a chance to clinch the drug industry’s biggest deal.
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May